Navigation Links
Inflection Biosciences licenses preclinical oncology programs from the CNIO
Date:6/4/2013

Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule treatments for cancer, today announced that it has entered into a license agreement with the Spanish National Cancer Research Centre (CNIO) for the exclusive, worldwide rights to develop and commercialise several novel kinase inhibitors for the treatment of cancer.

The compounds leverage the CNIO's considerable expertise in drug discovery and comprise a novel pan-PIM kinase inhibitor program and a number of unique multi-targeting kinase inhibitors combining activity on PIM kinase and additional kinases including the phosphoinositide-3 kinase and the mammalian target of rapamycin (PI3K/mTOR) pathway. All molecules have shown good activity in preclinical models, are orally- available with excellent pharmaceutical properties.

Dr María Blasco, Director of CNIO added "It is a great satisfaction for the CNIO to join forces with the experienced team at Inflection Biosciences, allowing us to take full advantage of our ability to innovate cancer treatments."

Dr Michael O'Neill, Co-Founder and Director of Research and Development at Inflection Biosciences commented "Following an extensive global search we are delighted to have secured assets in late preclinical stages of development of this quality and potential and from an organisation recognised internationally for the quality of its cancer research and its drug discovery programs."


'/>"/>

Contact: Press Office
comunicacion@cnio.es
Centro Nacional de Investigaciones Oncologicas (CNIO)
Source:Eurekalert

Page: 1

Related biology news :

1. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
2. Amarantus BioSciences to Present at the National Investment Banking Associations (NIBA)122nd Conference in New York City
3. 3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology
4. Althea Technologies & Profectus BioSciences Sign Manufacturing Agreement For Plasmid DNA Production
5. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
6. Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
7. Preclinical studies use specialized ultrasound to detect presence of cancer
8. Preclinical study shows potential of new technologies to detect response to cancer therapy earlier
9. AACR news: Paragazole excels in preclinical models of triple-negative breast cancer
10. ESMO 2012 Congress: A path for medical oncology innovations
11. TGen-US Oncology data guides treatment of metastatic triple-negative breast cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2019)... ... 2019 , ... Ava, a 115-pound Newfoundland, found herself in a predicament when, ... ligaments. Just one year later, she suffered the same injury in the opposite ... intervention and resumed her normal activities without any noticeable pain. Then, another setback. ...
(Date:2/6/2019)... ... February 05, 2019 , ... Amino Labs, ... partnered with MindFuel, a leading organization in educational science, technology, engineering and math ... Labs has pioneered a syn-bio starter kit for teachers – the Amino ...
(Date:1/30/2019)... ... January 30, 2019 , ... ... life science and biotechnology companies, announced today that it will host a ... venture funds to discuss their investment philosophies, explain their fund and deal ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... YANTAI, China and SAN DIEGO (PRWEB) , ... ... ... a leading and fully integrated Contract Development and Manufacturing Organization (CDMO) serving the ... has closed its series A funding of $59.1 million backed by multiple global ...
(Date:1/30/2019)... ... January 29, 2019 , ... Actus Therapeutics, a ... of the first patient in a phase 1/2 clinical study of ACTUS-101 in ... high morbidity and often leads to premature death. There are variable rates ...
(Date:1/30/2019)... ... January 29, 2019 , ... Could a computer detect ... a tricky math problem on an online tutoring program? Could it detect deep ... computer science assistant professor Erin Solovey is working to develop a ...
(Date:1/30/2019)... ... 30, 2019 , ... Through its Microbiome Grant Initiative ... study design, planning, sample collection, and analysis to a team of researchers at ... study the interactions between gut microbial composition and cardiovascular health risks, such as ...
Breaking Biology Technology: